0001209191-17-040672.txt : 20170616
0001209191-17-040672.hdr.sgml : 20170616
20170616194512
ACCESSION NUMBER: 0001209191-17-040672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170615
FILED AS OF DATE: 20170616
DATE AS OF CHANGE: 20170616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Andrew Kenneth William
CENTRAL INDEX KEY: 0001304113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 17917217
MAIL ADDRESS:
STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC.
STREET 2: 41 UNIVERSITY DRIVE
CITY: NEWTOWN
STATE: PA
ZIP: 18940
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-15
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001304113
Powell Andrew Kenneth William
C/O ACLARIS THERAPEUTICS, INC.
101 LINDENWOOD DRIVE, SUITE 400
MALVERN
PA
19355
1
0
0
0
Stock Option (right to buy)
24.58
2017-06-15
4
A
0
8000
0.00
A
2027-06-14
Common Stock
8000
8000
D
The shares underlying this option vest in twelve equal monthly installments through June 15, 2018, subject to the reporting person's continuous service as of such vesting date.
/s/ Brian F. Leaf, Attorney-in-Fact
2017-06-16